Skip to Main Content

Paper Details

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer.
Ther Adv Med Oncol
2
2023

Datasets

Release 1.2